Over a decade has passed since the first successful neonatal heart tra
nsplant was performed for palliation of hypoplastic left heart syndrom
e. Although neonates and infants represent a growing group of pediatri
c heart transplant recipients, survival remains inferior to that in ol
der children. Decisions regarding transplantation in infancy pose uniq
ue problems for the pediatric cardiologist, including limited donor av
ailability, pre-and posttransplant management, and improving results o
f alternative palliative surgery for hypoplastic left heart syndrome.
A number of recent articles provide important information about donor
availability, waiting times to transplantation, and outcome after list
ing and transplantation. Other studies focus on the treatment of infan
ts awaiting transplantation. Important laboratory investigations repor
ted this year focus on strategies for inducing immunologic tolerance (
the ''Holy Grail'' of the transplant physician) as well as ongoing res
earch in the controversial area of xenotransplantation.